Skip to main content

Blues health insurers put up $55 million to take on generic drugmakers

By Reuters  
   January 23, 2020

A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that aims to offer cheaper prices to their members on generic drugs that currently have little or no competition, the companies said on Thursday.

Full story

Get the latest on healthcare leadership in your inbox.